Edition:
India

Nanobiotix SA (NANOB.PA)

NANOB.PA on Paris Stock Exchange

15.14EUR
1:41pm IST
Change (% chg)

€0.01 (+0.07%)
Prev Close
€15.13
Open
€15.23
Day's High
€15.23
Day's Low
€15.11
Volume
7,788
Avg. Vol
184,474
52-wk High
€19.22
52-wk Low
€8.30

Chart for

About

Nanobiotix SA is a France-based oncology focused nanomedicine company. It is engaged in developing nanoparticle technology. It develops new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities. The Company's NanoXray... (more)

Overall

Beta: 1.61
Market Cap(Mil.): €301.54
Shares Outstanding(Mil.): 17.56
Dividend: --
Yield (%): --

Financials

BRIEF-Nanobiotix Did Not Generate Any Revenue In Q1

* ANNOUNCED ON TUESDAY IT DID NOT GENERATE ANY REVENUE FOR Q1 2018, AS IT HAD EXPECTED

16 May 2018

BRIEF-Nanobiotix Partners With Weill Cornell Medicine

* PARTNERSHIP ON PRE-CLINICAL STUDIES TO EVALUATE NBTXR3 IMPACT ON CGAS-STING PATHWAY IN MAMMARY CANCERS

03 May 2018

BRIEF-Nanobiotix FY Net Loss Widens to ‍​26.1 Million Euros

* TOTAL REVENUE IN 2017 AMOUNTS TO EUR 3.7M VERSUS. EUR 5.4M IN 2016

30 Mar 2018

Earnings vs. Estimates